Harrow Inc (NAS:HROW)
$ 45.8 -0.03 (-0.07%) Market Cap: 1.63 Bil Enterprise Value: 1.75 Bil PE Ratio: 0 PB Ratio: 27.76 GF Score: 61/100

Q4 2022 Harrow Health Inc Earnings Call Transcript

Mar 23, 2023 / 08:45PM GMT
Release Date Price: $17.25 (-0.12%)
Operator

Good afternoon, and welcome to Harrow's Q4 2022 Earnings Conference Call. My name is MJ, and I will be your operator for today's call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the call over to Jamie Webb, Director of Communications and Investor Relations for Harrow.

Jamie Webb
Harrow Health, Inc. - Director of Communications & IR

Thank you, operator. Good afternoon, and welcome to Harrow's Fourth Quarter and Year-end 2022 Earnings Conference Call. Before we begin today, let me remind you that the company's remarks may include forward-looking statements within the meaning of federal securities law. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond Harrow's control, including risks and uncertainties described from time to time in its SEC filings, such as the risks and uncertainties related to the company's ability to make commercially available its FDA-approved products and compounded formulations and technology and FDA approval of certain drug

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot